Paloma Partners’s Novo Nordisk NVO Stock Holding History

Paloma Partners’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,838	Closed	-$213K	–	1532
2022 Q1	$213K	Sell	3,838 -1,124	-23%	-$57.7K	0.01%	1357
2021 Q4	$278K	Buy	+4,962	New	+$269K	﹤0.01%	1443
2017 Q1	–	Sell	-137,822	Closed	-$2.47M	–	2152
2016 Q4	$2.47M	Buy	137,822 +124,948	+971%	+$2.27M	0.02%	553
2016 Q3	$268K	Sell	12,874 -4,156	-24%	-$103K	﹤0.01%	1658
2016 Q2	$458K	Sell	17,030 -4,604	-21%	-$126K	0.01%	1576
2016 Q1	$587K	Buy	21,634 +12,676	+142%	+$340K	0.01%	1221
2015 Q4	$260K	Sell	8,958 -1,326	-13%	-$36.7K	0.01%	1408
2015 Q3	$279K	Buy	+10,284	New	+$291K	0.01%	1312

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Paloma Partners's NVO Position: Q2 2022 in Review

Paloma Partners sold out of Novo Nordisk (NVO) in Q2 2022, closing a stake of 3,838 shares — an estimated $213K sold.

Paloma Partners first reported a position in NVO in Q3 2015 and held it in 8 quarters. The position peaked at $2.47M in Q4 2016. 932 funds tracked by Wall St. Rank hold NVO as of Q2 2022.

Paloma Partners reported no remaining Novo Nordisk position as of Q2 2022 after selling out during the quarter.
Paloma Partners sold 3,838 Novo Nordisk shares in Q2 2022, an estimated $213K.
Paloma Partners first reported a position in Novo Nordisk in Q3 2015 and held it in 8 quarters.
Paloma Partners's Novo Nordisk position peaked at $2.47M in Q4 2016.
932 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.

Based on Paloma Partners's 13F filing for Q2 2022, filed 15 Aug 2022.